why choose us

First received: May 22, 2024

Clinical Trial: A Prospective, Monocentric Clinical Study for the Validation of in Vitro Diagnostic Tests Developed by Firalis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Genetic Health Risks

Study Type: OBSERVATIONAL


Official Title: ApoDiag: A Prospective, Monocentric Clinical Study for the Validation of in Vitro Diagnostic Tests Developed by Firalis

Brief Summary: Firalis SA and its affiliate Amoneta Diagnostics SAS are developing novel in-vitro-diagnostic (IVD) tests for diverse diagnostic applications for major human diseases, including cardiovascular, and neurodegenerative disorders.These tests detect several gene mutations related to the above-mentioned pathologies.The development of IVD tools requires the evaluation of analytical parameters including biomarker stability.The present specific study therefore aims to collect whole blood samples in PAXgene DNA tubes to…

Read more